185 related articles for article (PubMed ID: 10507763)
41. Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas.
Okazaki I; Wada N; Nakano M; Saito A; Takasaki K; Doi M; Kameyama K; Otani Y; Kubochi K; Niioka M; Watanabe T; Maruyama K
Hepatology; 1997 Mar; 25(3):580-4. PubMed ID: 9049202
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
[TBL] [Abstract][Full Text] [Related]
43. ras oncogene p21 expression in hepatocellular carcinoma.
Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
[TBL] [Abstract][Full Text] [Related]
44. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
45. Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis.
Jaskiewicz K; Chasen MR
Anticancer Res; 1995; 15(2):559-62. PubMed ID: 7539239
[TBL] [Abstract][Full Text] [Related]
46. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
47. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
48. Distribution of asialoglycoprotein receptor in human hepatocellular carcinoma.
Hyodo I; Mizuno M; Yamada G; Tsuji T
Liver; 1993 Apr; 13(2):80-5. PubMed ID: 8389955
[TBL] [Abstract][Full Text] [Related]
49. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma.
Fujikawa K; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Takase K; Nakano T
Anticancer Res; 2000; 20(3B):1927-32. PubMed ID: 10928128
[TBL] [Abstract][Full Text] [Related]
50. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
51. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
52. Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma.
Kariyama K; Higashi T; Kobayashi Y; Nouso K; Nakatsukasa H; Yamano T; Ishizaki M; Kaneyoshi T; Toshikuni N; Ohnishi T; Fujiwara K; Nakayama E; Terracciano L; Spagnoli GC; Tsuji T
Br J Cancer; 1999 Nov; 81(6):1080-7. PubMed ID: 10576668
[TBL] [Abstract][Full Text] [Related]
53. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma.
Tan L; Fu XY; Liu SQ; Li HH; Hong Y; Wu MC; Wang HY
Liver Int; 2005 Jun; 25(3):667-76. PubMed ID: 15910504
[TBL] [Abstract][Full Text] [Related]
54. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
55. [Analysis of nuclear DNA heterogeneity of the hepatocellular carcinoma (HCC)].
Horiuchi H; Yamashita Y; Kamachi M; Sendo S; Kobayashi K; Yanase Y; Nakamura Y; Kakegawa T; Nakashima T
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():11-6. PubMed ID: 7515614
[TBL] [Abstract][Full Text] [Related]
56. Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers.
Nagao T; Ishida Y; Kondo Y
Mod Pathol; 1996 Feb; 9(2):99-104. PubMed ID: 8657727
[TBL] [Abstract][Full Text] [Related]
57. [Biological activity of hepatocellular carcinoma by analysing nuclear DNA ploidy patterns and using anti BrdU monoclonal antibody].
Jung-Rou T
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):168-80. PubMed ID: 2546033
[TBL] [Abstract][Full Text] [Related]
58. The pathway of the asialoglycoprotein-ligand during receptor-mediated endocytosis: a morphological study with colloidal gold/ligand in the human hepatoma cell line, Hep G2.
Geuze HJ; Slot JW; Strous GJ; Schwartz AL
Eur J Cell Biol; 1983 Nov; 32(1):38-44. PubMed ID: 6321187
[TBL] [Abstract][Full Text] [Related]
59. "Neuroendocrine" differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade.
Zhao M; Laissue JA; Zimmermann A
Histol Histopathol; 1993 Oct; 8(4):617-26. PubMed ID: 8305816
[TBL] [Abstract][Full Text] [Related]
60. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration cytology and biopsy study.
Ojanguren I; Ariza A; Llatjós M; Castellà E; Mate JL; Navas-Palacios JJ
Hum Pathol; 1993 Aug; 24(8):905-8. PubMed ID: 7690737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
